Research Fellow Pfizer Inc. Andover, Massachusetts
Industry perspective from companies like Pfizer, Moderna, Sanofi, GSK and/or BioNTech, etc. Academic perspective from someone like Peter Cullis, Gaurav Sahay, Yvonne Perie, etc. Questions for panel members will include Mechanistic understanding of LNP instabilities; Contribution of mRNA, Impact of choice of lipids, impact of process of fabrication, etc.
Learning Objectives:
Understand the current landscape of stability issues for mRNA LNPs
Learn about analytical tools and approaches to get a mechanistic understanding of the instabilities.
Learn about ways to overcome stability limitations.
